Atlas Trials

Study to Assess the Safety, Tolerability and Pharmacokinetics and Pharmacodynamics of AZD0284 in Healthy Subjects

Clinical trial NCT02976831 · COMPLETED

Trial details

NCT number
NCT02976831
Sponsor
AstraZeneca
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Plaque Psoriasis Vulgaris
Start date
2016-12-09
Primary completion
2017-05-30
Enrollment
83

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.